Celera is a molecular diagnostics business with powerful discovery platforms dedicated to the practice of Targeted Medicine. Located in Rockville, MD and Alameda, CA, the company employs about 300 people and has the full capability to discover, develop, manufacture and secure registration for In Vitro Diagnostic products.
To identify novel diagnostic markers and potential drug targets, we are leveraging capabilities in proteomics, genomics and bioinformatics to better understand the association between common diseases (cardiovascular, autoimmune and cancer) and patterns of genetic variation and protein expression. Our strategy is to be a leader in Targeted Medicine by producing new genetic and proteomic-based diagnostics tests that improve patient outcome by predicting disease risk, selecting the most effective therapy and monitoring treatment. Another goal is to capitalize on the value of our discoveries through partnerships to develop new therapies, identify new disease indications for existing drugs, and to provide pharmacogenomic and companion diagnostic tests.
Celera has a strategic alliance with Abbott Laboratories through which the companies sell and support molecular diagnostic products. Celera's discovery platforms are the basis for multiple discovery and therapeutic product development collaborations.
Prof. Hongxia Wang
We speak with Professor Hongxia Wang from QUT about a new project that hopes to utilize graphene and other low-cost carbon materials to produce commercially viable, ultra low-cost, flexible perovskite solar cells.
Moti Segev & Vlad Shalaev
In this interview, AzoNano speaks to Professor Moti Segev and Professor Vladimir Shalaev, who made surprising discoveries about photonic time crystals that challenge existing research and theories.
Siyu Chen, Ph.D.
In this interview, we discuss a new approach to surface-enhanced Raman spectroscopy that utilizes nano-pockets to capture target molecules, ensuring a highly sensitive way to detect chemical processes.
This product profile introduces graphene nanoribbons and which ones Merck sells.
The ClearView scintillator camera that elevates your everyday transmission electron microscopy (TEM).
Achieve high-throughput co-localized imaging and in-situ nanoindentation with Bruker’s Hysitron PI 89 Auto SEM.